Lexicon Pharmaceuticals, Inc. announced the resignation of Brian P. Zambrowicz, Ph.D., executive vice president and chief scientific officer, to pursue another opportunity. Dr. Zambrowicz will be assisting in shifting his responsibilities to other members of the company in order to ensure a seamless transition. In connection with the change, Lexicon will merge its discovery and clinical functions and conduct an immediate search for a head of research and development.

Dr. Zambrowicz has agreed to be available to provide consulting services as the company completes this transition.